TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis
出版年份 2014 全文链接
标题
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 4, Pages 436-444
出版商
Springer Nature
发表日期
2014-01-27
DOI
10.1038/onc.2013.569
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells
- (2013) Gilles Buchwalter et al. CANCER CELL
- High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer
- (2013) Philip M. Spanheimer et al. JOURNAL OF SURGICAL RESEARCH
- Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells
- (2013) C. O. dos Santos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AP2γ regulates neural and epidermal development downstream of the BMP pathway at early stages of ectodermal patterning
- (2012) Yunbo Qiao et al. CELL RESEARCH
- Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation
- (2012) F Bai et al. ONCOGENE
- FOXA1 represses the molecular phenotype of basal breast cancer cells
- (2012) G M Bernardo et al. ONCOGENE
- Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression
- (2012) Christian J. Gröger et al. PLoS One
- FoxM1 Regulates Mammary Luminal Cell Fate
- (2012) Janai R. Carr et al. Cell Reports
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
- (2012) Maria Kalyuga et al. PLOS BIOLOGY
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
- (2011) H E Lee et al. BRITISH JOURNAL OF CANCER
- AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription
- (2011) Si Kee Tan et al. EMBO JOURNAL
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium
- (2011) J. M. Balko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland
- (2010) Richard Jäger et al. DEVELOPMENTAL DYNAMICS
- Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells
- (2010) George W. Woodfield et al. GENES CHROMOSOMES & CANCER
- Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells
- (2009) He Ailan et al. BMC CANCER
- Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
- (2009) Jessica Kao et al. PLoS One
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Disruption of epidermal specific gene expression and delayed skin development in AP-2γ mutant mice
- (2008) Jillian Guttormsen et al. DEVELOPMENTAL BIOLOGY
- Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
- (2008) JMW Gee et al. JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started